Overview
If you had invested ₹
on
and stayed invested till
it would have become ₹ NaN i.e. CAGR of NaN%About Kotak Healthcare Fund
- Kotak Healthcare Fund - An open ended equity scheme investing in Pharma, Healthcare and allied sectors.
- The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Portfolio
Sector | Portfolio weight |
---|---|
Pharmaceuticals and Biotechnology | 82.15 % |
Healthcare Services | 17.01 % |
Net Current Assets | -0.5 % |
Type | % |
---|---|
Large Cap | 41.1 % |
Small Cap | 32.95 % |
Mid Cap | 25.11 % |
Others | 0.84 % |
Performance
Historical Returns (as per SEBI format) as on
Tenors | CAGR | Current Value of ₹ 10,000 invested | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Since Inception | 5Y | 3Y | 1Y | 6 M | Since Inception | 5Y | 3Y | 1Y | 6 M | |
Kotak Healthcare Fund - Direct (G) | 40.14% | - | - | 41.36% | 20.92% | 14,144.00 | - | - | 14,135.52 | 12,091.99 |
NIFTY Healthcare TRI | 41.10% | - | - | 42.98% | 16.83% | 14,243.22 | - | - | 14,298.08 | 11,683.04 |
As on Dec 20, 2024
Rolling Returns
1 Year | |||||
---|---|---|---|---|---|
Average | - | - | - | - | 40.86 |
Maximum | - | - | - | - | 42.47 |
Minimum | - | - | - | - | 39.68 |
% times +ve returns | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
% times returns > | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
The returns are of Direct Growth Plan. Returns are calculated since inception with daily rolling frequency for the respective periods.
SWP Calculator
Scheme Name : Kotak Healthcare Fund - Direct Plan Growth
NAV Date | NAV | Units | Cash Flow | Scheme Value |
---|
Historical Returns (as per SEBI format) as on 30 November 2024
Tenors | CAGR | Current Value of ₹ 10,000 invested | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Since Inception | 5Y | 3Y | 1Y | 6 M | Since Inception | 5Y | 3Y | 1Y | 6 M | |
Kotak Healthcare Fund - Direct (G) | 40.14% | - | - | 41.36% | 20.92% | 14,144.00 | - | - | 14,135.52 | 12,091.99 |
NIFTY Healthcare TRI | 41.10% | - | - | 42.98% | 16.83% | 14,243.22 | - | - | 14,298.08 | 11,683.04 |
Fund
Tier 1 Benchmark
Kotak Healthcare Fund (An open ended equity scheme investing in Pharma, Healthcare and allied sectors.)
This open ended fund Scheme is suitable for investors seeking - Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors
The above riskometer is based on the scheme portfolio as on 30 November 2024 . An addendum may be issued or updated on the website for new riskometer.
Start Date of the Investment is considered as 1st of Every Month. Exit Load, Stamp Duty & STT are ignored for ease of calculation. Data Source: We have considered NAV Direct Plan Growth Option for the above scheme, Past Performance may or may not be sustained in the future. In view of the individual nature of tax consequences, each unit holder is advised to consult their tax advisors. All figures and other data given in this document are as of 30 November 2024. The same may or may not be relevant at a future date. The AMC takes no responsibility for updating any data/information in this material from time to time. The information shall not be altered in any way, transmitted to, copied, or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without the prior written consent of Kotak Mahindra Asset Management Company Limited. Kotak Mahindra Asset Management Company Limited (including its affiliates), the Mutual Fund, The Trust and any of its officers, directors, personnel, and employees shall not be liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as well as any loss of profit, in any way arising from the use of this material in any manner. Further, the information contained herein should not be construed as a forecast or promise. The recipient alone shall be fully responsible/liable for any decision taken based on this material.
Mutual fund investments are subject to market risks, read all scheme related documents carefully.
Details
Fund Managers
Ms. Shibani Sircar Kurian See All Funds Managed
Mr. Abhishek Bisen See All Funds Managed
Mr. Dhananjay Tikariha See All Funds Managed
Portfolio turnover ratio
34.78%
Expense Ratio (Direct) **
0.74
Expense Ratio (Regular) **
2.39
Source: *ICRA MFI Explorer ## Risk rate assumed to be % (FBIL Overnight MIBOR rate as on NA) **Total Expense Ratio includes applicable B30 fee and GST.
Source: *ICRA MFI Explorer
## Risk rate assumed to be %
(FBIL Overnight MIBOR rate as on NA)
**Total Expense Ratio includes applicable B30 fee and GST.
Direct Plan and Regular PlanOptions: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)
Initial Investment: Rs. 5000/- and in multiples of Re. 1 for purchases and of Re. 0.01 for switches
Additional Investment: Rs. 1000/- and in multiples of Re. 1 for purchases and of Re. 0.01 for switches
Ideal Investments Horizon: 5 years And above
Entry Load: Nil
Exit Load: For redemption / within 30 days from the date of allotment: 1% If units are redeemed or switched out on or after 30 days from the date of allotment: NIL Any exit load charged (net off Goods and Services tax, if any) shall be credited back to the Scheme. Units issued on reinvestment of IDCWs shall not be subject to entry and exit load
Fund
Tier 1 Benchmark
Kotak Healthcare Fund (An open ended equity scheme investing in Pharma, Healthcare and allied sectors.)
This open ended fund Scheme is suitable for investors seeking - Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors